Evidence map›Paper›PMID 22719234›Full record

ArticlePLoS computational biology2012

Metabolic reconstruction for metagenomic data and its application to the human microbiome.

Sahar Abubucker, Nicola Segata, Johannes Goll, Alyxandria M Schubert, Jacques Izard, Brandi L Cantarel, Beltran Rodriguez-Mueller, Jeremy Zucker, Mathangi Thiagarajan, Bernard Henrissat and 7 more

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 617 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
617citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

617 citing papers in PubMed, 2 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. [Advances in the Application of Forensic Microbiome Analysis in Tissue Source Inference].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

557 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 2 countries.

Sahar AbubuckerThe Genome Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Nicola Segata
Johannes Goll
Alyxandria M Schubert
Jacques Izard
Brandi L Cantarel
Beltran Rodriguez-Mueller
Jeremy Zucker
Mathangi Thiagarajan
Bernard Henrissat
Owen White
Scott T Kelley
Barbara Methé
Patrick D Schloss
Dirk Gevers
Makedonka Mitreva
Curtis Huttenhower
Harvard University Press · USJ. Craig Venter Institute · USBroad Institute · USUniversity of Maryland, Baltimore · USUniversity of Michigan–Ann Arbor · USWashington University in St. Louis · USAix-Marseille Université · FRHarvard University · USSan Diego State University · US

Funding

Sequencing the Human MicrobiomeU54HG004968 · NHGRI · WASHINGTON UNIVERSITY · PI WEINSTOCK, GEORGE M · 2009 to 2012
$16.7M
Defining the Human MicrobiomeU54HG004969 · NHGRI · BROAD INSTITUTE, INC. · PI BIRREN, BRUCE W. · 2009 to 2012
$10.3M
Molecular Mechanisms of Microbial Pathogenesis Training ProgramT32AI007528 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CARRUTHERS, VERNON BRUCE · 1998 to 2024
$6.8M
Functional activity and inter-organismal interactions in the human microbiomeR01HG005969 · NHGRI · HARVARD SCHOOL OF PUBLIC HEALTH · PI HUTTENHOWER, CURTIS · 2010 to 2012
$1.3M
Identifying population-level variation in cross-sectional and longitudinal HMP stR01HG005975 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHLOSS, PATRICK DAVID · 2010 to 2012
$1.1M
Treponema denticola cytoskeletal filaments and oral infectionR21DE017106 · NIDCR · ADA FORSYTH INSTITUTE, INC. · PI IZARD, JACQUES G. · 2007 to 2008
$440k
SEROLOGICAL MARKERS OF PERIODONTAL DISEASE AND PANCREATIC CANCER RISKR21CA139193 · NCI · BROWN UNIVERSITY · PI IZARD, JACQUES G., MICHAUD, DOMINIQUE S. · 2010 to 2011
$439k
NCI NIH HHS CA139193NCI NIH HHS R21 CA139193NHGRI NIH HHS 1R01HG005969NHGRI NIH HHS 5R01HG005975NHGRI NIH HHS R01 HG005969NHGRI NIH HHS R01 HG005975NHGRI NIH HHS U54 HG004968NHGRI NIH HHS U54HG004968NHGRI NIH HHS U54 HG004969NHGRI NIH HHS U54HG004969NIDCR NIH HHS DE017106NIDCR NIH HHS R21 DE017106
6 · The paper itself

Abstract

Microbial communities carry out the majority of the biochemical activity on the planet, and they play integral roles in processes including metabolism and immune homeostasis in the human microbiome. Shotgun sequencing of such communities' metagenomes provides information complementary to organismal abundances from taxonomic markers, but the resulting data typically comprise short reads from hundreds of different organisms and are at best challenging to assemble comparably to single-organism genomes. Here, we describe an alternative approach to infer the functional and metabolic potential of a microbial community metagenome. We determined the gene families and pathways present or absent within a community, as well as their relative abundances, directly from short sequence reads. We validated this methodology using a collection of synthetic metagenomes, recovering the presence and abundance both of large pathways and of small functional modules with high accuracy. We subsequently applied this method, HUMAnN, to the microbial communities of 649 metagenomes drawn from seven primary body sites on 102 individuals as part of the Human Microbiome Project (HMP). This provided a means to compare functional diversity and organismal ecology in the human microbiome, and we determined a core of 24 ubiquitously present modules. Core pathways were often implemented by different enzyme families within different body sites, and 168 functional modules and 196 metabolic pathways varied in metagenomic abundance specifically to one or more niches within the microbiome. These included glycosaminoglycan degradation in the gut, as well as phosphate and amino acid transport linked to host phenotype (vaginal pH) in the posterior fornix. An implementation of our methodology is available at http://huttenhower.sph.harvard.edu/humann. This provides a means to accurately and efficiently characterize microbial metabolic pathways and functional modules directly from high-throughput sequencing reads, enabling the determination of community roles in the HMP cohort and in future metagenomic studies.

Indexed as

MetagenomeComputational BiologyDigestive SystemFemaleGenetics, MicrobialGlycosaminoglycansHumansHydrogen-Ion ConcentrationMetabolic Networks and PathwaysMetabolomeMultigene FamilyVaginaGlycosaminoglycans

Identifiers

PMID22719234
PMCPMC3374609
OpenAlexW1497287772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.